Matthew Eaton

Matthew Eaton

Company: Precede Biosciences

Job title: Vice President Computational Biology and Bioinformatics


Implications of Patient Selection When Utilizing Novel ADC Targets 11:30 am

Identifying what is relevant in pre-treated patients Discussing biomarkers to identify patients who will respond well to an ADC target Targeting certain oncology patients in a novel methodRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.